Suggestions
Chris Von Seggern
Chief Commercial Officer at Xenon Pharmaceuticals Inc.
Chris Von Seggern, Ph.D., MPH, MBA, is the Chief Commercial Officer at Xenon Pharmaceuticals Inc., a position he has held since August 2020.13 He is employed by Xenon Pharmaceuticals USA Inc., a wholly owned subsidiary of Xenon Pharmaceuticals Inc.1
Professional Background
Before joining Xenon, Dr. Von Seggern had an extensive career in healthcare consulting:
- He was a Partner at ClearView Healthcare Partners from 2011 to 2019.1
- His tenure at ClearView spanned from 2008 to 2019, where he focused on the pharmaceutical sector, particularly in orphan diseases and transformational technologies.1
- Prior to ClearView, he served as a Consultant for Leerink Swann Strategic Advisors from 2006 to 2008.1
Responsibilities and Expertise
As Chief Commercial Officer, Dr. Von Seggern:
- Oversees the commercial strategy and execution for Xenon's neurology-focused pipeline.3
- Brings broad experience in managing commercial engagements across multiple therapeutic areas.1
- Has expertise in strategic due diligence for in-licensing and M&A opportunities.1
Education
Dr. Von Seggern holds multiple advanced degrees:
- Ph.D. (presumably in a relevant scientific field)
- Master of Public Health (MPH)
- Master of Business Administration (MBA)1
His educational background combines scientific expertise with public health knowledge and business acumen, which likely contributes to his effectiveness in his current role.
Location and Professional Network
Dr. Von Seggern is based in the Greater Boston area and has a substantial professional network, with over 500 connections on LinkedIn.2 His profile on the platform has approximately 2,000 followers, indicating a significant presence in his professional community.2
